Skip to main content
Ronaldo Go, MD, Pulmonology, Hackensack, NJ

Ronaldo Collo Go MD

Critical Care Medicine, Pleural Disease


Physician

Join to View Full Profile
  • 30 Prospect AvenueDepartment of Internal MedicineHackensack, NJ 07601

  • Phone+1 551-996-3500

  • Fax+1 551-996-3298

Dr. Go is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

  • Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
  • Connect with colleagues in the same hospital or clinic.
  • Read the latest clinical news, personalized to your specialty.

Education & Training

  • Icahn School of Medicine at Mount Sinai/Mount Sinai Hospital
    Icahn School of Medicine at Mount Sinai/Mount Sinai HospitalFellowship, Pulmonary Disease and Critical Care Medicine, 2010 - 2013
  • Maimonides Medical Center
    Maimonides Medical CenterResidency, Internal Medicine, 2007 - 2009
  • Atlantic Health System/Overlook Medical Center
    Atlantic Health System/Overlook Medical CenterInternship, Internal Medicine, 2006 - 2007
  • Angeles University Foundation
    Angeles University FoundationClass of 2004

Certifications & Licensure

  • MA State Medical License
    MA State Medical License 2009 - 2026
  • NC State Medical License
    NC State Medical License 2009 - 2025
  • NJ State Medical License
    NJ State Medical License 2015 - 2025
  • NY State Medical License
    NY State Medical License 2010 - 2025
  • Internal Medicine
    American Board of Internal Medicine Internal Medicine
  • Critical Care Medicine
    American Board of Internal Medicine Critical Care Medicine
  • Pulmonary Disease
    American Board of Internal Medicine Pulmonary Disease

Publications & Presentations

PubMed

Journal Articles

  • Tocilizumab in Hospitalized Patients with Severe Covid-19 Pneumonia  
    Ivan O Rosas, Ronaldo C Go, Ivor S Douglas, Larry Tsai, Atul Malhotra, The New England Journal of Medicine
  • Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational Study  
    Noa Biran, Andrew Ip, Ronaldo Collo Go, The Lancet Rheumatology

Authored Content

  • Hydroxychloroquine and tocilizumab therapy in COVID-19 patients-An observational studyAugust 2020
  • Tocilizumab Among Patients with COVID-19 in the Intensive Care Unit: A Multicentre Observational StudyAugust 2020

Viewing the full profile is available to verified healthcare professionals only.

Find your profile and take control of your online presence: